Ignite Creation Date:
2024-05-06 @ 8:28 PM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06395064
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-01
First Post:
2024-04-29
Brief Title:
The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy Randomized-controlled Trial
Sponsor:
Preeyaporn Jirakittidul
Organization:
Mahidol University
Study Overview
Official Title:
The Effect of Dimenhydrinate on Postoperative Nausea and Vomiting After Abdominal Hysterectomy Randomized-controlled Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this clinical trial is to learn if Dimenhydrinate works to prevent postoperative nausea-vomiting in adult women who undergoing abdominal hysterectomy The primary question is Does Dimenhydrinate lower the proportion of postoperative nauseavomiting during the day 1 after surgery Researcher will compare Dimenhydrinate to a placebo a-look-alike substance that contains no drug which will give intravenously when the patient come back to the ward to see if Dimenhydrinate work to prevent nauseavomiting during the postoperative day1 All participants will receive standard treatment during pre-operative intra-operative and the immediate post-operative periods Participants will receive Dimenhydrinate or placebo only one dose after discharge from the recovery room During the day 1 postoperative participants will report their symptoms and keep a diary of the number of tmes they use additional anti-emetic drugs
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None